# Task V20: Hamster Sarbecovirus Challenge Model for SARS-CoV-2 Vaccine Testing

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2024 · $2,365,162

## Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. Task areas include: 1) administrative management and technical support including training and workshops, and quality oversight and management (site visits, critical stage audits, and final study report audits), 2) development, qualification and validation of immune assays, 3) immunogenicity and efficacy testing, 4) non-clinical and clinical sample testing, and 5) safety/toxicology studies. These services will facilitate the development and introduction of new vaccine candidates and biologics (regulated by CBER) against potential agents of bioterrorism and emerging and re-emerging infectious diseases.

## Key facts

- **NIH application ID:** 11202805
- **Project number:** 272201800013I-0-759302400001-1
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** THOMAS RUDGE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,365,162
- **Award type:** —
- **Project period:** 2024-09-06 → 2026-09-05

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11202805

## Citation

> US National Institutes of Health, RePORTER application 11202805, Task V20: Hamster Sarbecovirus Challenge Model for SARS-CoV-2 Vaccine Testing (272201800013I-0-759302400001-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11202805. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*